Skip to content
10-K

Annual Report

GUIDED THERAPEUTICS INC GTHP

0001477932-24-001549

← back to feed
Filed
Mar 28, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Mar 28, 2024 55.61M sh
Capex FY 2023 · Dec 31, 2023 $0
Capex FY 2023 · Dec 31, 2022 $31K
Shares Diluted FY 2023 · Dec 31, 2022 32.51M sh
Operating Cash Flow restated FY 2023 · Dec 31, 2022 −$1.48M
Current Liabilities FY 2023 · Dec 31, 2022 $4.87M
Total Liabilities FY 2023 · Dec 31, 2022 $6.25M
Current Assets FY 2023 · Dec 31, 2022 $3M
Total Assets FY 2023 · Dec 31, 2022 $3.37M
Eps Diluted FY 2023 · Dec 31, 2022 −$0.15
Eps Basic FY 2023 · Dec 31, 2022 −$0.15
Sga Expense FY 2023 · Dec 31, 2022 $3.01M
Rd Expense FY 2023 · Dec 31, 2022 $77K
Net Income FY 2023 · Dec 31, 2022 −$4.34M
Operating Income FY 2023 · Dec 31, 2022 −$3.33M
Gross Profit FY 2023 · Dec 31, 2022 −$68K
Revenue FY 2023 · Dec 31, 2022 $13K
Stockholders Equity FY 2023 · Dec 31, 2021 −$5.45M